Study of Predictors of Clinical Outcomes in Patients With HR+ and HER2-low/Negative Breast Cancer

Conditions:   Hormone-receptor-positive Breast Cancer;   HER2-low Breast Cancer;   HER2-negative Breast Cancer Intervention:   Other: No drug Sponsor:   Daiichi Sankyo, Inc. Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials